Testing Solutions for SARS-CoV-2 Vaccine Development

Vaccine immunogenicity testing, flow cytometry, and genomic analysis


This recorded presentation provides an overview of select methodologies available at Q2 Solutions that aid in vaccine development for SARS-CoV-2. The methodologies covered in this presentation are:

  • Vaccine immunogenicity, neutralization assays and T-cell response assessment with Bob Bailer, Ph.D., Sr. Director, Vaccines
  • Cutting-edge next generation flow cytometry with Mark Edinger, Director, Scientific Affairs, Flow Cytometry
  • Genomic analysis: Host genome/transcriptome and viral sequencing with Pat Hurban, Ph.D., Sr. Director and Global Head, Translational Genomics